Complications alleged from the use of AlloDerm
AlloDerm® Regenerative Tissue Matrix (“AlloDerm”) is a biologic allograft product manufactured by LifeCell Corporation.
Surgeons use AlloDerm in abdominal repair surgeries, hernia repair surgeries, and other reconstructive surgeries. There have been patient complaints of having experienced complications from the use of AlloDerm in their surgery. Hernia recurrence appears to be the primary complication, but there have been reports of other serious injuries, including infections, adhesive failure, and massive scar tissue development.
AlloDerm lawsuits have been filed in New York and New Jersey. Recently, there has been an application pursuant to Directive #7-09 of the New Jersey Revised Mass Tort Guidelines to designate all New Jersey state-court litigation involving the human tissue graft sold under the trade name AlloDerm® Regenerative Tissue Matrix as a mass tort.
The litigation alleges that the failure of the manufacture violated the New Jersey Products Liability Act (“PLA”) in designing, developing, processing, manufacturing, testing, packaging, advertising, promoting, marketing, distributing, labeling, and/or selling AlloDenn. The Plaintiffs claim that AlloDerm was sold with inadequate warnings and instructions as to its natural properties and its potential failure rate, and these failures were a direct and proximate result of the damages sustained.
If you or a loved one has experienced a complications relating to the use of AlloDerm in a surgical repair, you should speak to a personal injury lawyer to evaluation your claim and protect your interests.